Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia.

@article{Vaddadi1992UseOG,
  title={Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia.},
  author={Krishna S Vaddadi},
  journal={Prostaglandins, leukotrienes, and essential fatty acids},
  year={1992},
  volume={46 1},
  pages={67-70}
}
  • Krishna S Vaddadi
  • Published 1992 in
    Prostaglandins, leukotrienes, and essential fatty…
There is good background evidence to suggest that essential fatty acids and their eicosanoid derivatives may play a role in schizophrenia and in with tardive dyskinesia. Trials involving treatment with essential fatty acids, or eicosanoids or drugs which stimulate eicosanoid synthesis have shown modestly promising results. Particularly favourable outcomes in both schizophrenia and tardive dyskinesia were associated with combined treatment using essential fatty acids and nutritional supplements. 

From This Paper

Topics from this paper.

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…